导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -11.44% | 852/1050 |
| 近一周 | -1.51% | 566/1104 |
| 近一月 | -2.67% | 481/1103 |
| 近一季 | -14.21% | 841/1092 |
| 近半年 | -19.06% | 984/1070 |
| 近一年 | -8.34% | 723/1018 |
| 近两年 | 46.43% | 535/926 |
| 近三年 | 6.99% | 615/834 |
| 成立以来 | 202.24% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.47% 383/1070 |
-0.68% 712/1101 |
- - |
- - |
| 2025 | 27.34% 525/1065 |
7.46% 252/1014 |
-0.37% 716/1038 |
21.57% 555/1050 |
-2.17% 566/1065 |
| 2024 | -0.20% 588/1011 |
-8.24% 704/960 |
-5.96% 689/983 |
12.43% 423/991 |
2.86% 209/1011 |
| 2023 | 0.62% 89/952 |
16.12% 45/880 |
-2.32% 323/895 |
-6.40% 385/915 |
-5.22% 534/952 |
| 2022 | -16.53% 209/867 |
-15.98% 309/773 |
3.97% 581/806 |
-12.11% 396/845 |
8.72% 104/867 |
| 2021 | 32.90% 56/740 |
8.39% 15/580 |
-0.26% 547/659 |
7.76% 87/704 |
14.07% 31/740 |
| 2020 | 38.42% 307/554 |
-1.58% 202/419 |
12.02% 385/466 |
13.18% 174/517 |
10.93% 337/554 |
| 2019 | 41.18% 211/410 |
25.05% 698/1146 |
-4.85% 696/1228 |
7.43% 154/390 |
10.45% 151/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 汇丰晋信价值先锋股票A VS. 东吴新产业精选股票A(580008) |